RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients.

@article{Derosa2013RETRACTEDEO,
  title={RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients.},
  author={Giuseppe Derosa and Pietro Dario Ragonesi and Anna Carbone and Elena Fogari and Angela D'Angelo and Arrigo Francesco Giuseppe Cicero and Pamela Maffioli},
  journal={Pharmacological research},
  year={2013},
  volume={73},
  pages={20-6}
}
We evaluated the positive effects of vildagliptin in addition to metformin on glycemic control and β-cell function in type 2 diabetic patients. One hundred and seventy-one type 2 diabetic patients were instructed to add vildaglipin 50mg twice a day or placebo to metformin for 12 months. Body mass index (BMI), glycemic control, fasting plasma insulin (FPI), HOMA-IR, HOMA-β, fasting plasma proinsulin (FPPr), proinsulin/fasting plasma insulin ratio (Pr/FPI ratio), C-peptide, glucagon, vaspin… CONTINUE READING
Blog posts, news articles and tweet counts and IDs sourced by
Altmetric.com